GTC Biotherapeutics (fka GTCB)

[voodoo in my basemen]

With the dispute between JL and Vinny it is clear we are comming to a moment that it is obvious that something is on the brink to happen.
I see you both arguing in a way a BOD is discussing this.
(I think that medium sized BP and small sized BP is not interested ( and probably can not afford) the losses of Biotech’s start ups and companies like GTCB).

Jesse I can understand your point of view regarding the initial start ups (pleonasm?) and their links to cell culture. I think that’s a fact. So ok forget these start up’s. If a company is willing to take a certain risk all parameters of the small biotech will be taken into account. So be it; entrepeneurs.
But I think it’s a fact also what Vinny states. If you are to discuss where to put your money as BP the slide of consensus in a board room is, or will alter towards what is or will be in the medium run so let say 4/three years, profitable. Not as to diversify and broaden the portfolio (I don’t think this is a niche market, it requires a separate unit under the holding of a company) but as a strategic move.

The approval in this scenario is (was) of the same importance as the legislation towards FOB and FOBB will be.

I don’t think is a mere coincidence that Ovation is taken over the day after approval, and the next step whitin this scenario lays the hands of the legislation. As soon they shift towards cost reduction, and that moment maybe not so far seen the exploding costs of handling the credit crunch, GTCB has signed a contract yet.